1. Endothelin-1 (21-amino acids) and pre-pro endothelin-1 (39-amino ac
ids) produced a concentration-dependent increase in perfusion pressure
when infused through the renal artery of rabbit isolated perfused kid
ney. Addition of phosphoramidon to the medium caused a potentiation in
the vasoconstrictor response to endothelin-1 and greatly, but not com
pletely, inhibited vasoconstriction induced by pre-pro-endothelin-1. 2
. Addition of indomethacin to the medium did not alter the vasoconstri
ctor effects of the peptides. 3. Methylene blue in the medium caused a
highly significant potentiation in the vasoconstrictor response to en
dothelin-1. 4. A short-term infusion of endothelin-1 through the renal
artery elicited a decrease in urine flow which returned to control le
vels after perfusing the kidney with Krebs buffer, but prolonged infus
ion of the peptide produced an irreversible increase in urine flow. 5.
Phosphoramidon, methylene blue and indomethacin failed to alter the e
ffect of endothelin-1 on urine how. 6. From these results it was concl
uded that phosphoramidon-sensitive endothelin-converting enzyme, proba
bly localized in microvasculature of the kidney, can convert pre-pro-e
ndothelin-1 to endothelin-1 which is responsible for the vasoconstrict
or effect of pre-pro-endothelin-1 in addition to its possible direct v
asoconstrictor effect on kidney vasculature. Moreover, the endothelin-
1 degradating enzyme in kidney should be a phosphoramidon-sensitive me
talloproteinase(s). The results also indicated the release of EDRF but
not prostanoids by endothelin-peptides in the rabbit isolated perfuse
d kidney.